Quintrio
Home

Stock overview

Local Bounti Corporation

LOCL

Local Bounti Corp is a controlled environment agriculture company. The business model is based on building local facilities, operated by local teams, to deliver fresh and quality produce to local communities while maintaining a limited carbon footprint. Using proprietary technology to grow leafy greens and herbs in smart greenhouses with a cultivation process that uses less water and land than conventional agriculture, free from herbicides or pesticides. The products of the company include living lettuce, leafy greens, herbs, and others.

Last trade $0.63
Day change -$0.005 (-0.79%)
Day range $0.635 – $0.828
Volume 46,769
Market cap $15M

Open XNYS

Fundamentals

Key company ratios and reported financial statements.

Source: Massive.com

Key ratios

Valuation

Market capitalization
$14.96M
Price / earnings
—
Price / book
-0.08×
Price / sales
0.29×
EV / sales
10.67×
EV / EBITDA
-15.08×

Profitability

Earnings per share
-$2.89
Return on assets
-16.8%
Return on equity
34.37%
Dividend yield
0%

Liquidity and leverage

Debt / equity
-2.75×
Current ratio
1.07×
Quick ratio
0.72×
Cash ratio
0.17×

Cash flow

Price / cash flow
—
Price / free cash flow
—
Free cash flow
-$28.36M

Ratios use trailing-twelve-month financials and market data as of Nov 16, 2026.

Financial statements

Income and cash flow amounts are for the period; balance sheets are point-in-time snapshots. Amounts are shown in USD. Latest 8 quarterly or 5 annual periods are displayed when available.

Income statement for LOCL, quarterly periods
Line itemQ2 FY2026 Jun 30, 2026Q1 FY2026 Mar 31, 2026Q4 FY2025 Dec 31, 2025Q3 FY2025 Sep 30, 2025Q2 FY2025 Jun 30, 2025Q1 FY2025 Mar 31, 2025Q4 FY2024 Dec 31, 2024Q3 FY2024 Sep 30, 2024
Revenue$13.85M$13.34M$12.46M$12.2M$12.1M$11.61M$10.07M$10.24M
Cost of revenue$12.8M$11.8M$10.94M$10.79M$10.63M$10.14M$9.53M$8.83M
Gross profit$1.05M$1.53M$1.52M$1.41M$1.47M$1.46M$540K$1.41M
Selling, general and administrative$10.42M$9.75M$9.31M$12.95M$10.44M$10.22M$10.13M$12.35M
Research and development$4.58M$5.72M$5.44M$6.68M$6.49M$6.98M$7.19M$7.1M
Total operating expenses$14.99M$15.47M$14.74M$19.63M$16.92M$17.2M$17.31M$19.44M
Operating income-$13.95M-$13.93M-$13.22M-$18.22M-$15.45M-$15.73M-$16.77M-$18.03M
Interest expense-$4.49M-$4.03M$28M-$4.56M-$4.6M-$18.84M$40.42M-$18.31M
Income before taxes-$19.82M-$12.72M-$8.7M-$26.43M-$21.58M-$37.68M-$36.26M-$34.33M
Income taxes$0$0$0$0$0$0$0$0
Net income-$19.82M-$12.72M-$8.7M-$26.43M-$21.58M-$37.68M-$36.26M-$34.33M
Net income attributable to common shareholders-$19.82M-$12.72M-$8.7M-$26.43M-$21.58M-$38.08M-$36.26M-$34.33M
EBITDA-$8.38M-$8.31M-$7.61M-$12.37M-$9.59M-$9.85M-$10.89M-$12.16M
Basic earnings per share-$0.68-$0.53-$0.38-$1.18-$1.63-$4.32-$4.21-$4.01
Diluted earnings per share-$0.68-$0.53-$0.38-$1.18-$1.63-$4.32-$4.21-$4.01

Recent news

Company coverage with links to the original publishers.

Publication times in UTC
Benzinga

What's Going On With Local Bounti Shares On Wednesday?

Local Bounti (NYSE:LOCL) shares fell 21.31% in premarket trading on Wednesday despite reporting mixed Q4 2025 results with 27% annual revenue growth, improved margins, and better-than-expected earnings. The company expects steady sequential improvement in 2026 but faces technical headwinds with an overbought RSI of 82.07, suggesting potential pullback pressure.

Benzinga

Why Ultragenyx Pharmaceutical Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Monday's Mid-Day Session

Shares of Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) fell sharply during Monday’s session after the company revealed new data from the Phase 1/2 study of GTX-102 for Angelman syndrome, a genetic disorder causing developmental disabilities and nerve-related symptoms. Ultragenyx Pharmaceutical shares dipped 9.4% to $42.46 on Monday. Here are some other stocks moving in today's mid-day session. Gainers Soligenix, Inc. (NASDAQ: SNGX) shares surged 71.5% to $0.6679 after the company announced that it was granted orphan drug designation to the active ingredient in MarVax for the prevention and post-exposure prophylaxis against MARV infection by the FDA. Longeveron Inc. (NASDAQ: LGVN) surged 54% to $2.6350 following insider buys from multiple company executives. SuperCom Ltd. (NASDAQ: SPCB) shares gained 39.4% to $0.3849 after jumping around 18% on Friday. Piedmont Lithium Inc. (NYSE: PLL) shares gained 32.1% to $16.75 following a 5% decline on Friday. Snap One Holdings Corp. (NASDAQ: SNPO) surged 31.6% to $10.71 after the company announced that it will be acquired by Resideo Technologies. Organovo Holdings, Inc. (NASDAQ: ONVO) shares surged 30.9% to $1.32 after the company announced Phase 2 results for FXR314. Study results demonstrated statistically significant reduction in liver fat content from baseline in patients receiving FXR314 compared to placebo. Kuke Music Holding Limited (NASDAQ: KUKE) jumped 27% to $2.7650. HUB Cyber Security Ltd. (NASDAQ: HUBC) gained 24% to $1.61 after gaining over 11% on Friday. Edgio, Inc. (NASDAQ: EGIO) gained 24% to $22.18. Kaival Brands Innovations Group, Inc. (NASDAQ: KAVL) ...

Zacks Investment Research

Cibus (CBUS) Reports Q4 Loss, Tops Revenue Estimates

Cibus, Inc. (CBUS) delivered earnings and revenue surprises of -3.57% and 308.52%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?

Dividends

Declared distributions and recorded event dates. Forecasts are not shown.

Updated daily

No declared upcoming dividend found.

No prior dividend records found.

Stock splits

Historical share-structure events and their execution dates.

Updated daily
Execution dateSplit ratioEvent type
Jun 15, 20231-for-13reverse split